Molecular responses to therapeutic proteasome inhibitors in multiple myeloma patients are donor-, cell type- and drug-dependent.

about

Molecular responses to therapeutic proteasome inhibitors in multiple myeloma patients are donor-, cell type- and drug-dependent.

Item

http://www.wikidata.org/entity/Q55027177

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Molecular responses to therape ...... cell type- and drug-dependent.

@en

Molecular responses to therape ...... cell type- and drug-dependent.

@nl

type

Item

label

Molecular responses to therape ...... cell type- and drug-dependent.

@en

Molecular responses to therape ...... cell type- and drug-dependent.

@nl

prefLabel

Molecular responses to therape ...... cell type- and drug-dependent.

@en

Molecular responses to therape ...... cell type- and drug-dependent.

@nl

P1476

Molecular responses to therape ...... cell type- and drug-dependent.

@en

P2093

Efstathios Kastritis

http://www.w3.org/2001/XMLSchema#string

Eleni-Dimitra Papanagnou

http://www.w3.org/2001/XMLSchema#string

Evangelos Terpos

http://www.w3.org/2001/XMLSchema#string

Ioannis P Trougakos

http://www.w3.org/2001/XMLSchema#string

Issidora S Papassideri

http://www.w3.org/2001/XMLSchema#string

Ourania E Tsitsilonis

http://www.w3.org/2001/XMLSchema#string

P2860

The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1

p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription

Initial genome sequencing and analysis of multiple myeloma

Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma

Identification of the yeast 20S proteasome catalytic centers and subunit interactions required for active-site formation.

The active sites of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing.

Stress-activated cap'n'collar transcription factors in aging and human disease

Proteasome dysfunction in Drosophila signals to an Nrf2-dependent regulatory circuit aiming to restore proteostasis and prevent premature aging.

Drug screening using model systems: some basics

Biological and chemical approaches to diseases of proteostasis deficiency

P304

17797-17809

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.24882

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Meletios A. Dimopoulos

P577

2018-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29707147

http://www.w3.org/2001/XMLSchema#string

P932

5915155

http://www.w3.org/2001/XMLSchema#string